The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults. The approval was supported by data from th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback